This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Pfizer Corporation. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012
Title: Scott Santford Woodard: Innovator in Pharmaceutical Chemistry
Introduction
Scott Santford Woodard is a notable inventor based in Manchester, Missouri. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that serve as inhibitors for specific biological processes.
Latest Patents
Woodard holds a patent for "Pyrazole derivatives as 5-LO-inhibitors." This invention relates to compounds of formula (I), detailing processes for their preparation, their use as 5-lipoxygenase inhibitors, and pharmaceutical compositions that contain these compounds. His innovative work in this area has the potential to impact therapeutic approaches significantly.
Career Highlights
Woodard is currently employed at Pfizer Corporation, a leading global pharmaceutical company. His role at Pfizer allows him to engage in cutting-edge research and development, contributing to the advancement of medical science and patient care.
Collaborations
Throughout his career, Woodard has collaborated with talented professionals, including Edgardo Alvira and Matthew James Graneto. These collaborations have fostered a productive environment for innovation and discovery in the pharmaceutical sector.
Conclusion
Scott Santford Woodard exemplifies the spirit of innovation in the pharmaceutical industry through his patent work and collaborations. His contributions are paving the way for new therapeutic options and enhancing the understanding of complex biological processes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile